AndhraNews.net
Home » Features » Organizations » European Union

European Union


The European Union (EU) is a unique economic and political union of 27 member states which are located primarily in Europe.

The EU has developed a single market through a standardised system of laws which apply in all member states. The EU is represented at the United Nations, the WTO, the G8 and the G-20.

Key People

  • Andrew Standley - EU ambassador to Israel

Sanctions against Iran

The European Union has laid new sanctions against Iran on 15 October 2012 over the disputed nuclear program. The sanctions include banning trade in industries like finance, metals and natural gas. The business transaction which will get affected will worse the damage to the Iran's economy.

European Union in News

Basilea provides clinical program updates
Basilea Pharmaceutica AG /Basilea provides clinical program updates. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Novartis announces NEJM publication of two major trials showing significant efficacy of Cosentyx in ankylosing spondylitis patients
Novartis International AG /Novartis announces NEJM publication of two major trials showing significant efficacy of Cosentyx in ankylosing spondylitis patients . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Lifeline Biotechnologies Summarizes 2015, Looks Forward to 2016
The Company (OTC PINK: LLBO) updates the meaningful activities for the year of 2015 and looks ahead for 2016.

TiGenix files Registration Statement for proposed initial public offering in the United States
Leuven (BELGIUM) - December 22, 2015, 22:30h CET - TiGenix NV (Euronext Brussels: TIG; the "Company"), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platforms of allogeneic expanded stem cells, announced today that it has filed a Registration Statement on Form F-1 with the U.S

HeartStitch(R) Lectures at CSI 2015 - Structural Heart Congress, Frankfurt Germany
The HeartStitch® 'tradition' of important announcements every year at CSI continued this year as Prof. Nobles, HeartStitch® CEO, lectured on the clinical results generated by the company's latest devices. These latest clinical results underscored HeartStitch's solid reputation for innovation; uncomplicated, cardiologist-focused design; and sheer effectiveness.

Nobles Medical Technologies II Board Strengthened by Union Capital Group SA's Antoine Felicelli
Nobles Medical Technologies II announced today the election of Antoine Felicelli, Chief Operating Officer of Union Capital Group SA in Geneva, to its Board of Directors. The election took place at a stockholders meeting held in November, 2015. Prior to his election, Mr. Felicelli had been appointed to the Board in July of 2015 to fill an existing vacancy. Mr

Ad hoc: Amgen acquires Medigene spin-off Catherex
Medigene AG /Keyword(s): Contract /Ad hoc: Amgen acquires Medigene spin-off Catherex. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Final allocations of Basilea CHF 200 million senior convertible bonds
Basilea Pharmaceutica AG /Final allocations of Basilea CHF 200 million senior convertible bonds. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Bavarian Nordic Enters Licensing and Collaboration Agreement with Janssen for MVA-BN® in the Development of a Therapeutic HPV Vaccine

More Than 16 Million Babies Born Into Conflict This Year: UNICEF
NEW YORK, NY--(Marketwired - December 17, 2015) - More than 16 million babies were born in conflict zones in 2015 -- 1 in 8 of all births worldwide this year -- UNICEF said today, a figure that underscores the vulnerability faced by increasing numbers of children.

Allurion Technologies' Elipse (TM) Gastric Balloon Receives European Marketing Approval
WELLESLEY, MA--(Marketwired - December 17, 2015) - Allurion Technologies announced today that its Elipse™ Gastric Balloon has received a CE mark allowing sale of the product in the European Union. This is the company's first regulatory approval. Elipse™ will initially be available in select leading weight loss centers in France, Italy and the United Kingdom

Global Consumption Growth Drives California Walnut Growers
FRESNO, CA--(Marketwired - December 15, 2015) - Positive walnut consumption growth in emerging countries like Australia, South America, South-East Asia and the European Union will drive global consumption trends in upcoming years. Consumption in more mature markets such as China and the U.S. will continue to grow, albeit at a slightly slower rate

Structural Heart Congress SHC, to Be Held in Astana, Kazakhstan
HeartStitch©, Inc. Sponsors Structural Heart Congress in Kazakhstan bringing Internationally Renowned Doctors to the first annual SHC congress with a focus on stroke, migraine and other disorders caused by PFO, a structural heart abnormality that affects 27% of the world's population.

NMT II Live PFO Closure Creates Stir at Global Meeting of Cardiologists
For the first time in the company's history, NMT II announces that a Live case was successfully performed on camera, and transmitted in real time to the Congress for CSI -- attended by over 1,100 of the world's top cardiologist and physicians. A video of the case can be seen at http://www.csi-congress.org/?go=605.

Basilea successfully places CHF 200 million senior convertible bonds
Basilea Pharmaceutica AG /Basilea successfully places CHF 200 million senior convertible bonds. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Basilea launches a senior convertible bond issue
Basilea Pharmaceutica AG /Basilea launches a senior convertible bond issue. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

SpectraScience Study Confirms Accuracy of WavSTAT4 in the Diagnosis of Small Colorectal Cancer Polyps
SAN DIEGO, CA--(Marketwired - December 08, 2015) - SpectraScience, Inc. (OTCQB: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that in a presentation at United European Gastroenterology Week (UEGW) by Dr

World's First Intrinsically Safe Windows 10 Tablet Approved for Hazardous Locations in Europe, Middle East, Africa and Asia
LONDON, UNITED KINGDOM--(Marketwired - December 08, 2015) - The world's first intrinsically safe, Windows 10, Intel-based tablet, developed by Aegex Technologies LLC, has gained certification for use in hazardous locations in Europe and multiple international regions, including the Middle East, Africa and Asia Pacific

Spain’s SENSAR Makes a Commitment to the Patient Safety Movement Foundation
Business Wire IndiaThe Patient Safety Movement Foundation announced a commitment from Spain’s anesthesia national incident reporting system, Sistema Español de Notificacion en Seguridad on Anestesia y Reanimacion (SENSAR), to help eradicate medical errors

IH2 Technology Demonstration Plant to Be Built
Business Wire IndiaShell India Markets Pvt Ltd (SIMPL) will proceed with the installation of a 5 tonne/day IH2 technology demonstration plant on the site of SIMPL’s new Technology Centre in Bangalore, India. SIMPL will build, operate and own the demonstration scale IH2 plant

NN Group completes sale of its stake in ING-BOB Life to BNP Paribas Cardif
NN Group announced today that it has completed the sale of its 50% stake in its Chinese insurance joint venture ING-BOB Life Insurance Company to BNP Paribas Cardif.

NN Group new title sponsor of Marathon Rotterdam and City-Pier-City Run The Hague
NN Group is pleased to announce that it has chosen running as its main sport sponsoring domain. NN just finalised a three-year title sponsorship agreement with the Marathon Rotterdam and the City-Pier-City Run (CPC) in The Hague

Camille Albane Hair Salon Franchise Continues U.S. Expansion in Dallas
Camille Albane, the dominant upscale hair salon franchise in the European Union since 1994, is pleased to announce a March 2015 opening of its newest U.S. salon in Addison, Texas, a northern suburb of Dallas.

Anglo Pacific Group PLC: Re-classification of Listing
Anglo Pacific Group PLC (TSX: APY) (LSE: APF)

TiGenix submits its pivotal US trial design for Cx601 to the FDA for Special Protocol Assessment

Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease
Swedish Orphan Biovitrum AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc

Swissmedic approves Basilea's antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia
Basilea Pharmaceutica AG /Swissmedic approves Basilea's antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Flowserve MEN/ME Family of Water Pumps Updated to Meet New Energy Efficiency Standards in European Union
Water Pumps Designed to Reduce Customers' Total Cost of Ownership

Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder
Novartis International AG /Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL
MorphoSys AG /MorphoSys's MOR208 Program Receives Positive Opinion for Orphan Medicinal Product Designation from EMA for DLBCL . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Novartis announces results of trial evaluating the use of Afinitor® in first-line treatment in HER2+ advanced breast cancer at SABCS
Novartis International AG /Novartis announces results of trial evaluating the use of Afinitor® in first-line treatment in HER2+ advanced breast cancer at SABCS . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Kenilworth Systems Sells Patent Holdings to Interactive Systems
Kenilworth Systems Corp. (OTC PINK: KENS) today announced a significant step forward advancing shareholder value.

STMicroelectronics and Politecnico di Milano Build FASTER 3D Graphics Application using FPGAs

iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting
iBio, Inc

Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC® in Prostate Cancer
KVISTGAARD, Denmark, December 10, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that it has reached the planned enrollment of 1,200 patients in the PROSPECT Phase 3 clinical study of its targeted active immunotherapy candidate, PROSTVAC®, in the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

TiGenix starts Phase I trial of Cx611 in severe sepsis
PRESS RELEASE

Avangate Clients Automatically Compliant to Major EU VAT Regulation Change
Avangate, the leading Digital Commerce solution provider trusted by thousands of Software, Cloud and Online Services companies to grow their business worldwide, today announced that it is ready to accommodate the forthcoming European Union Value Added Tax regulation changes and ensure all Avangate clients will automatically remain VAT compliant

SEI Introduces AIFMD Annex IV Reporting Solution to Help Alternative Managers Meet New Transparency Rules
SEI (NASDAQ: SEIC) has expanded the regulatory compliance component of its global operating platform to include new capabilities that help alternative investment fund managers meet Annex IV transparency reporting requirements under the European Union Alternative Investment Fund Managers Directive (AIFMD)

Anuna Education and Adecco India to Provide Job Placements for Skill Development Students
Anuna Education, a partner of National Skill Development Corporation (NSDC) with a mandate to train & place over 1.1 lakh students, has signed a MoU for placement of skill development graduates with leading international placement firm Adecco India

Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant

CytoSorbents Provides Clinical Update on CytoSorb Dosing Study
CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company working to control inflammation and save lives in the ICU through blood purification with its European Union approved CytoSorb® cytokine filter, provides an end-of-year update on its CytoSorb® Dosing study that is currently ongoing.

Recap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio Interview
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company today announced that Michael Yorba of Clear Channel's Business Talk Radio Show, The Traders Network, interviewed CEO Dr. Eugene Seymour live on December 19, 2013.

ANORO(TM) ELLIPTA(TM) Approved as First Once-Daily Dual Bronchodilator for the Treatment of COPD in the US
GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc

Actelion provides an update in regard to Asahi litigation
Actelion Pharmaceuticals Ltd /Actelion provides an update in regard to Asahi litigation. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Sandoz begins Phase III clinical trial for biosimilar adalimumab
Novartis International AG /Sandoz begins Phase III clinical trial for biosimilar adalimumab. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

King & Spalding Wins $250 Million Arbitration Award for Micula Against Government of Romania
In one of the largest arbitration awards on record at the International Centre for the Settlement of Investment Disputes (ICSID) -- and one that could have an impact on the evolution of international law -- King & Spalding secured a $250 million victory for Micula in a long-running investment treaty arbitration against the Republic of Romania.

Reminder: Capital Link to Host Its 15th Annual Greek Investor Forum in New York City on December 17, 2013
On Tuesday, December 17, 2013, in cooperation with the New York Stock Exchange, Capital Link will host its 15th Annual Greek Investor Forum in New York City on the "New Era of Opportunity for Greece."

CytoSorbents Reports on Successful DIVI 2013 Conference
CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter to treat life-threatening illnesses in the intensive care unit, reports on its recent activities at the DIVI 2013 Congress in Leipzig, Germany.

Inspiring the next generation of farmers
Nestlé S.A. /Inspiring the next generation of farmers. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Capital Link to Host Its 15th Annual Greek Investor Forum in New York City on December 17, 2013
On Tuesday, December 17, 2013, in cooperation with the New York Stock Exchange, Capital Link will host its 15th Annual Greek Investor Forum in New York City on the "New Era of Opportunity for Greece."

Northern Power Systems Awarded TUV Rheinland Certification
ZURICH, SWITZERLAND--(Marketwired - December 06, 2013) - Northern Power Systems, a next-generation wind turbine technology company, announced today that it has been awarded TÜV Rheinland certification.

GSK and Theravance Announce Positive Results From Pivotal Phase III Study for Fluticasone Furoate/Vilanterol in Asthma
GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from a phase III efficacy and safety study of fluticasone furoate "FF"/vilanterol "VI" designed to support a potential filing for an asthma indication for adults in the US.

Actelion announces share buyback program - up to 10 million shares over a maximum of three years through the first trading line for reactive servicing of employee share ownership schemes
Actelion Pharmaceuticals Ltd /Actelion announces share buyback program - up to 10 million shares over a maximum of three years through the first trading line for reactive servicing of employee share ownership schemes . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Correcting and Replacing: UL DQS India Launches ‘Energie’ Project
UL DQS India, the Indian subsidiary of DQS Holding GmbH and the provider of management systems certification to various industries, launched ‘Energie’ project in Chennai today amidst eminent personalities from the energy and sustainability industry across India

Unisys and Steria Chosen to Modernize European Commission Tax and Customs Communications Network
Unisys Corporation’s (NYSE: UIS) Belgian subsidiary and Steria, a leading provider of IT-enabled business services, today announced a Unisys-led consortium has won a framework contract to modernize the mission-critical communications network used by European Union member states to share customs and tax information and protect against tax and customs fraud

UL DQS India Launches ‘Energie’ Project
UL DQS India, the Indian subsidiary of DQS Holding GmbH and the provider of management systems certification to various industries, launched ‘Energie’ project in Chennai today amidst eminent personalities from the energy and sustainability industry across India

Gemalto receives awards for advancing M2M technology across Europe
Regulatory News:

Apira Science, Inc. Accelerates Global Growth Through Exclusive Distribution Partnership with China Central Pharmaceuticals
Apira Science, Inc. has named China Central Pharmaceuticals Ltd. its exclusive distributor of the iGrow® Hair Growth System in the Chinese market. The partnership highlights Apira’s growing success in the global market, and showcases the burgeoning international demand for a safe and effective hair loss solution

Seattle Genetics and Takeda Highlight Long-term Follow-up Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Clinical Trials in Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma at ASH 2013
Seattle Genetics, Inc

New Data Presented at ASH Annual Meeting Enhance Understanding of PNH and aHUS to Provide Optimal Care for Patients with These Life-threatening Disorders
Alexion Pharmaceuticals, Inc

Hansen Medical to Present at the 31st Annual J.P. Morgan Healthcare Conference
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that President and CEO Bruce Barclay is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference. The conference is being held January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco, California

First Advantage Executive Achieves CIPP/E Certification
First Advantage, the leading global provider of comprehensive talent acquisition solutions, today announced that Traci Canning, senior vice president and managing director for Europe/Middle East/Africa (EMEA), has earned European privacy certification from the International Association of Privacy Professionals (IAPP).

Novartis drug Exjade® approved by European Commission for iron overload in patients with non-transfusion-dependent thalassemia
Novartis International AG /Novartis drug Exjade® approved by European Commission for iron overload in patients with non-transfusion-dependent thalassemia . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Actelion's novel antibiotic cadazolid to move into Phase III clinical development in patients suffering from Clostridium difficile associated diarrhea
Actelion Pharmaceuticals Ltd /Actelion's novel antibiotic cadazolid to move into Phase III clinical development in patients suffering from Clostridium difficile associated diarrhea . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Nikkei 225 Closes Higher as Exports Slide for 6th Month -- City Index Asia
City Index Asia

New Nerve Stimulation Treatment Study at LGH Designed to Ease Chronic Heart Failure Symptoms in Patients
Vascular surgeons and electrophysiologists at Lancaster General Hospital are participating in a new study to find out whether nerve stimulation can relieve heart failure symptoms as well as slow the progression of this prevalent disease.

IPSO Alliance Facilitates Rapid Growth of IoT and M2M Markets in 2012, Looks Forward to Continued Success in 2013
The Internet of Things has arrived! 2012 was the year that infrastructure providers around the globe permanently enabled IPv6, cementing the Internet Protocol as THE enabler of the world's widest range of innovative applications, particularly for smart objects

DS-Concept Looks Back at a Successful Year 2012
German Trade Financer DS-Concept has once more managed to strengthen its position in its key markets. "Our existing offices have exceeded expectations by showing an average growth of 20% on turnover," says Ansgar Hütten, CEO of DS-Concept Factoring GmbH in Mönchengladbach, Germany (http://www.ds-concept.net)

GSK and Theravance Announce Regulatory Submission for UMEC/VI (LAMA/LABA) in the US
GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application in the US for the investigational once-daily LAMA/LABA combination medicine, UMEC/VI, for patients with chronic obstructive pulmonary disease (COPD).

CargoSmart Signs Agreement With NACCS Center for Japan Customs' Advance Filing Rules
CargoSmart Limited, a leading Software as a Service (SaaS) global shipping and logistics solutions provider, today announced it is one of the first service providers to sign an agreement with Nippon Automated Cargo and Port Consolidated System, Inc

Actelion's ponesimod successful in mid-stage trial in patients with moderate to severe chronic plaque psoriasis - Ponesimod to proceed to Phase III clinical development in psoriasis
Actelion Pharmaceuticals Ltd /Actelion's ponesimod successful in mid-stage trial in patients with moderate to severe chronic plaque psoriasis - Ponesimod to proceed to Phase III clinical development in psoriasis . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder
Novartis International AG /Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

As Competitors Pursue Alternatives Medgenics' INFRADURE Gains Prominence for its Potential to Treat Hepatitis
Medgenics' (NYSEAMEX: MDGN) INFRADURE(TM) provides sustained productionand delivery of interferon-alpha for the treatment of hepatitis. INFRADURE(TM) is a kind of miniature pump that is impacted into the patient and continuously produces and release the desired protein into the patient's system

Biotie: Selincro(TM) (nalmefene) receives positive opinion for approval in the European Union
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 14 December 2012 at 14:10

Actelion announces acceptance of the New Drug Application for macitentan by the US Food and Drug Administration
Actelion Pharmaceuticals Ltd /Actelion announces acceptance of the New Drug Application for macitentan by the US Food and Drug Administration . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Hansen Medical Announces Changes to Its Board of Directors
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced changes to its Board of Directors. These changes include the appointment of Michael Eagle, a current director, as Chairman of the Board and the resignations of Russell C. Hirsch, M.D., Ph.D., and James M. Shapiro. Mr. Eagle replaces Dr. Hirsch as the Company's lead outside director

Graphite Market Set for Growth
Graphite, commonly known for its use in No 2 pencils, is quietly finding new applications that are poised to greatly expand its demand in the coming years

ELIQUIS® (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved ELIQUIS® (apixaban) for the prevention of ischemic stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF)

Philip Morris International Comments on the European Commission’s Proposed Revision of the Tobacco Products Directive
Philip Morris International Inc.’s (PMI) (NYSE/Euronext Paris: PM) Vice President, Communications, Julie Soderlund, issued the following has statement commenting on the European Commission’s proposal for the revision of the Tobacco Products Directive:

Actress Debasree Roy Supports Humane Society International’s Be Cruelty-Free Campaign to End Cosmetics Animal Testing in India
Award-winning actress and Trinamool Congress party MLA Debasree Roy has given her backing to Humane Society International/India’s Be Cruelty-Free campaign, the largest-ever global effort to end animal testing for cosmetics

Comment on this story

Share